pCRISPRia-v2 载体 (V000732)

我们所展示的质粒图谱主要是从文献和开放数据库中收集而来,主要是为了方便研究工作,其中一小部分质粒进行了质量控制,可供科学家使用。

所有的产品都严格仅供科学研究使用,不能应用于临床试验,包括人体摄入、注射或外用的药理学用途。

确保质粒的关键元件正确,但是我们并不能保证实验结果。页面展示的图谱序列为理论序列,可能与测序结果不一致,请自行比对后确定是否满足要求。(如果测过序,本页面一般会提供下载)

开放数据库中的大多数载体序列都没有被完全测序。如果实际序列与参考序列的相似度超过99%,则将其视为正确。

由于科学研究是在探索未知,具有很大的不确定性,在任何情况下,我们都不承担超出质粒本身的额外经济损失或责任。

载体名称:
pCRISPRia-v2
载体抗性:
Ampicillin
载体长度:
8893 bp
载体类型:
Mammalian Expression, Lentiviral, CRISPR
复制子:
ori
筛选标记:
Puromycin
拷贝数:
High Copy
启动子:
EF-1α
克隆方法:
Restriction Enzyme
5'引物:
gcgccaattctgcagacaaa
3'引物:
CCTTCTCTAGGCACCGGTTC

pCRISPRia-v2 载体图谱

pCRISPRia-v28893 bp40080012001600200024002800320036004000440048005200560060006400680072007600800084008800RREgp41 peptideProtein TatcPPT/CTSloxPmU6-FEF-1-alpha promoterPuroRT2ATagBFPloxPWPREKS primer5' LTR (truncated)oriAmpRAmpR promoterpRS-markerCMV enhancerCMV promoter5' LTR (truncated)HIV-1 Psi

质粒操作方法

1. 发货形式:质粒干粉(常温运输,存于-20度,请务必先转化提质粒后使用)

2. 收到质粒干粉后请先5000rpm离心1min,再加入20μl ddH2O溶解质粒;(质粒复测的浓度有时候与标称值差距较大,这可能是因为冻干质粒在管中的位置、复溶效率、测量偏差以及管壁的吸附导致,因此建议先转化提质粒后再使用)

3. 取1支100μl 感受态于冰上解冻10min,加入2μl质粒,再冰浴30min后,42℃热激60s,不要搅动,再冰浴2min;

4. 加入900μl无抗的LB液体培养基,180rpm震荡37℃培养45min (30℃培养1-1.5小时);

5. 6000rpm离心5min,仅留100μl上清液重悬细菌沉淀,并涂布至目标质粒抗性的LB平板上;

6. 将平板倒置37℃培养14h,如果要求是30℃则培养20h; (菌落过多则将质粒稀释后再转化;没有菌落则加入10μl质粒转化;建议不要直接转表达感受态, 要先转克隆感受态,重提质粒后再导入表达感受态);

7. 挑取单菌落至LB液体培养基中,加入对应抗生素,220rpm震荡培养14h,根据实验需要和质粒提取试剂盒说明书提取质粒。

pCRISPRia-v2 载体序列

LOCUS       V000732                 8893 bp    DNA     circular SYN 20-DEC-2021
DEFINITION  Exported.
ACCESSION   V000732
VERSION     V000732
KEYWORDS    pCRISPRia-v2
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
            .
REFERENCE   1  (bases 1 to 8893)
  AUTHORS   Horlbeck MA, Gilbert LA, Villalta JE, Adamson B, Pak RA, Chen Y,
            Fields AP, Park CY, Corn JE, Kampmann M, Weissman JS
  TITLE     Compact and highly active next-generation libraries for
            CRISPR-mediated gene repression and activation.
  JOURNAL   Elife. 2016 Sep 23;5. pii: e19760. doi: 10.7554/eLife.19760.
   PUBMED   27661255
REFERENCE   2  (bases 1 to 8893)
  TITLE     Direct Submission
REFERENCE   3  (bases 1 to 8893)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName: "Elife.";
            date: "2016-09-23"; pages: "
            10.7554/eLife.19760"
            SGRef: number: 2; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..8893
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     misc_feature    293..526
                     /label="RRE"
                     /note="The Rev response element (RRE) of HIV-1 allows for
                     Rev-dependent mRNA export from the nucleus to the
                     cytoplasm."
     CDS             711..755
                     /label="gp41 peptide"
                     /note="antigenic peptide corresponding to amino acids 655
                     to 669 of the HIV envelope protein gp41 (Lutje Hulsik et
                     al., 2013)"
     CDS             904..945
                     /note="Protein Tat from Human immunodeficiency virus type 1
                     group M subtype B (isolate WMJ22). Accession#: P12509"
                     /label="Protein Tat"
     misc_feature    1053..1170
                     /label="cPPT/CTS"
                     /note="central polypurine tract and central termination
                     sequence of HIV-1"
     protein_bind    1431..1464
                     /label="loxP"
                     /bound_moiety="Cre recombinase"
                     /note="Cre-mediated recombination occurs in the 8-bp core
                     sequence (GCATACAT)."
     primer_bind     1468..1488
                     /label="mU6-F"
                     /note="Mouse U6 promoter, forward primer"
     promoter        1728..2900
                     /label="EF-1-alpha promoter"
                     /note="strong constitutive promoter for human elongation
                     factor EF-1-alpha"
     CDS             2912..3508
                     /label="PuroR"
                     /note="puromycin N-acetyltransferase"
     CDS             3518..3571
                     /codon_start=1
                     /product="2A peptide from Thosea asigna virus capsid
                     protein"
                     /label="T2A"
                     /note="Eukaryotic ribosomes fail to insert a peptide bond
                     between the Gly and Pro residues, yielding separate
                     polypeptides."
                     /translation="EGRGSLLTCGDVEENPGP"
     CDS             3584..4279
                     /label="TagBFP"
                     /note="monomeric blue fluorescent protein"
     protein_bind    complement(4302..4335)
                     /label="loxP"
                     /note="Cre-mediated recombination occurs in the 8-bp core
                     sequence (ATGTATGC) (Shaw et al., 2021)."
     misc_feature    4391..4979
                     /label="WPRE"
                     /note="woodchuck hepatitis virus posttranscriptional
                     regulatory element"
     primer_bind     complement(4982..4998)
                     /label="KS primer"
                     /note="common sequencing primer, one of multiple similar
                     variants"
     LTR             5508..5688
                     /label="5' LTR (truncated)"
                     /note="truncated 5' long terminal repeat (LTR) from HIV-1"
     rep_origin      complement(5750..6338)
                     /direction=LEFT
                     /label="ori"
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
                     replication"
     CDS             complement(6512..7369)
                     /label="AmpR"
                     /note="beta-lactamase"
     promoter        complement(7370..7474)
                     /label="AmpR promoter"
     primer_bind     complement(7549..7568)
                     /label="pRS-marker"
                     /note="pRS vectors, use to sequence yeast selectable
                     marker"
     enhancer        7740..8119
                     /label="CMV enhancer"
                     /note="human cytomegalovirus immediate early enhancer"
     promoter        8120..8322
                     /label="CMV promoter"
                     /note="human cytomegalovirus (CMV) immediate early
                     promoter"
     LTR             8337..8517
                     /label="5' LTR (truncated)"
                     /note="truncated 5' long terminal repeat (LTR) from HIV-1"
     misc_feature    8564..8689
                     /label="HIV-1 Psi"
                     /note="packaging signal of human immunodeficiency virus
                     type 1"